Market closed
CureVac/$CVAC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CureVac
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Ticker
$CVAC
Sector
NON_CLASSIFIED
Trading on
NASDAQ
Industry
Biotechnology & Drugs
Headquarters
Tuebingen, Germany
Employees
999
Website
CureVac Metrics
BasicAdvanced
$873M
-
-$1.32
2.67
-
Price and volume
Market cap
$873M
Beta
2.67
52-week high
$12.36
52-week low
$2.22
Average daily volume
22M
Financial strength
Current ratio
2.25
Quick ratio
2.094
Long term debt to equity
7.955
Total debt to equity
9.094
Management effectiveness
Return on assets (TTM)
-32.85%
Return on equity (TTM)
-47.11%
Return on investment (TTM)
-38.88%
Valuation
Price to revenue (TTM)
13.641
Price to book
1.801
Price to tangible book (TTM)
1.937
Growth
Revenue change (TTM)
17.59%
Earnings per share change (TTM)
14.35%
3-year revenue growth (CAGR)
3.23%
What the Analysts think about CureVac
Analyst Ratings
Majority rating from 9 analysts.
CureVac Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€12M
-45.33%
Net income
-€71M
-18.59%
Profit margin
-573.17%
48.92%
CureVac Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-€0.30
-€0.22
-€0.39
-€0.31
-
Expected
-€0.24
-€0.23
-€0.19
-€0.23
-€0.24
Surprise
25.00%
3.51%
110.81%
35.96%
-
CureVac News
AllArticlesVideos
CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
Accesswire·2 weeks ago
CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CureVac stock?
CureVac (CVAC) has a market cap of $873M as of April 24, 2025.
What is the P/E ratio for CureVac stock?
The price to earnings (P/E) ratio for CureVac (CVAC) stock is 0 as of April 24, 2025.
Does CureVac stock pay dividends?
No, CureVac (CVAC) stock does not pay dividends to its shareholders as of April 24, 2025.
When is the next CureVac dividend payment date?
CureVac (CVAC) stock does not pay dividends to its shareholders.
What is the beta indicator for CureVac?
CureVac (CVAC) has a beta rating of 2.67. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.